Expression of CD302 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

CD302 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 6.86

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

11.7

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	44.1
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	31.2
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	28.0
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	26.6
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	26.3
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	23.2
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	22.4
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	21.7
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	21.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	21.5
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	21.5
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	21.4
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	21.3
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	20.9
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	19.8
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	19.4
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	19.1
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	18.6
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	18.6
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	18.0
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	17.9
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	17.0
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	17.0
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	16.9
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	16.8
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	16.8
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	16.7
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	16.0
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	15.9
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	15.9
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	15.8
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	15.8
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	15.6
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	15.5
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	15.4
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	15.3
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	15.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	14.7
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	14.7
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	14.5
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	14.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	14.3
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	14.2
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	14.0
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	14.0
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	13.9
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	13.9
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	13.8
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	13.5
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	13.3
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	13.1
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	12.8
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	12.8
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	12.7
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	12.6
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	12.6
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	12.5
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	12.4
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	12.4
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	12.3
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	11.9
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	11.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	11.8
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	11.7
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	11.6
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	11.4
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	11.0
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	10.9
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	10.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	10.9
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	10.9
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	10.7
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	10.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	10.6
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	10.5
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	10.2
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	10.2
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	10.1
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	10.1
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	10.1
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	9.9
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	9.9
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	9.8
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	9.8
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	9.7
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	9.2
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	9.1
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	9.1
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	9.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	8.7
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	8.6
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	8.6
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	8.6
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	8.5
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	8.3
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	8.2
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	8.0
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	8.0
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	7.9
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	7.5
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	7.4
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	7.3
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	7.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	7.1
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	6.9
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	6.8
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	6.8
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	6.7
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	6.6
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	6.5
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	6.4
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	6.4
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	6.4
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	6.3
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	6.2
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	6.2
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	6.2
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	6.0
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	6.0
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	5.4
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	5.4
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	5.3
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	5.3
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	5.2
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	4.2
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	4.2
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	4.2
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	4.1
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	3.8
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	3.8
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	3.6
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	3.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	3.3
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	3.2
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	3.2
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	3.2
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	3.2
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	3.0
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	2.4
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	2.3
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	2.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

CD302 is potential prognostic, high expression is unfavorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 10.59

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

12.2

Number of samples

Samples

Sample	Description	TPM
AK030	N, NA, stage:NA, dead, 120 days	45.4
AK005	N, NA, stage:NA, dead, 240 days	40.2
AK195	N, NA, stage:NA, dead, 390 days	22.0
AK188	N, NA, stage:NA, alive, 420 days	21.3
AK185	N, NA, stage:NA, alive, 330 days	18.2
AK167	N, NA, stage:NA, dead, 180 days	17.7
AK226	N, NA, stage:NA, dead, 360 days	17.5
AK099	N, NA, stage:NA, dead, 420 days	17.3
AK035	N, NA, stage:NA, dead, 210 days	16.6
AK227	N, NA, stage:NA, alive, 300 days	16.0
AK049	N, NA, stage:NA, dead, 180 days	15.9
AK153	N, NA, stage:NA, dead, 240 days	15.9
AK218	N, NA, stage:NA, dead, 180 days	15.7
AK079	N, NA, stage:NA, dead, 210 days	15.1
AK183	N, NA, stage:NA, alive, 360 days	14.9
AK006	N, NA, stage:NA, dead, 360 days	14.6
AK081	N, NA, stage:NA, dead, 180 days	14.4
AK051	N, NA, stage:NA, dead, 360 days	14.2
AK133	N, NA, stage:NA, dead, 360 days	13.9
AK117	N, NA, stage:NA, dead, 210 days	13.4
AK139	N, NA, stage:NA, dead, 270 days	12.8
AK098	N, NA, stage:NA, dead, 660 days	12.8
AK091	N, NA, stage:NA, dead, 210 days	12.7
AK071	N, NA, stage:NA, dead, 540 days	12.6
AK156	N, NA, stage:NA, dead, 330 days	12.6
AK088	N, NA, stage:NA, dead, 360 days	12.5
AK002	N, NA, stage:NA, dead, 570 days	12.5
AK003	N, NA, stage:NA, dead, 600 days	12.4
AK236	N, NA, stage:NA, dead, 360 days	11.8
AK089	N, NA, stage:NA, dead, 330 days	11.7
AK053	N, NA, stage:NA, dead, 300 days	11.3
AK158	N, NA, stage:NA, dead, 360 days	10.7
AK124	N, NA, stage:NA, alive, 1920 days	10.5
AK066	N, NA, stage:NA, alive, 960 days	10.4
AK123	N, NA, stage:NA, dead, 180 days	10.0
AK149	N, NA, stage:NA, dead, 420 days	9.7
AK173	N, NA, stage:NA, dead, 180 days	9.7
AK100	N, NA, stage:NA, alive, 960 days	9.6
AK103	N, NA, stage:NA, alive, 1320 days	9.1
AK085	N, NA, stage:NA, alive, 660 days	9.0
AK216	N, NA, stage:NA, dead, 360 days	8.6
AK134	N, NA, stage:NA, dead, 360 days	8.2
AK231	N, NA, stage:NA, dead, 240 days	8.0
AK165	N, NA, stage:NA, alive, 360 days	7.7
AK178	N, NA, stage:NA, dead, 240 days	7.4
AK205	N, NA, stage:NA, dead, 120 days	7.2
AK055	N, NA, stage:NA, dead, 240 days	7.2
AK015	N, NA, stage:NA, alive, 720 days	6.6
AK199	N, NA, stage:NA, alive, 1860 days	6.1
AK074	N, NA, stage:NA, alive, 300 days	5.2
AK068	N, NA, stage:NA, alive, 360 days	5.0
AK076	N, NA, stage:NA, alive, 660 days	4.6
AK072	N, NA, stage:NA, dead, 150 days	4.5
AK142	N, NA, stage:NA, alive, 90 days	4.5
AK102	N, NA, stage:NA, alive, 1740 days	4.2
AK041	N, NA, stage:NA, alive, 810 days	3.7
AK213	N, NA, stage:NA, alive, 2010 days	2.8
AK043	N, NA, stage:NA, alive, 660 days	2.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis